Wednesday, May 9, 2012

>CAVEAT EMPTOR: CAPITAL RULES AND DELEVERAGING CAN MAKE "BARGAIN" BANKS EXPENSIVE

The stress test of the European Banking Authority last year led to the conclusion that numerous banks, including major listed banks, would need additional capital to support the continuation of existing activities. Official estimates started low, but eventually converged on over 100 billion euros for the banks; even these numbers seem low compared to the real needs if banks were to maintain their former book of business, as enumerated in my earlier study. The numbers seemed much larger that what the markets or the banks' home countries could provide and the price of bank stocks tanked at the end of 2011.


To read paper in detail: CAVEAT EMPTOR
RISH TRADER

>EDUCOMP SOLUTIONS


Not convinced about overall governance


Educomp’s fortunes appear to be declining fast in light of reduced funding from banks. We reiterate our view that the SPE will be consolidated once India converges to IFRS from 2013 onwards which will lead to negative OCF and FCF and D/E c.2:1. Management now
has admitted this. Our concerns on overall governance policies go further, principally: a common address of the auditor and the registered office of Edu Smart; cost allocation of resource coordinators and high turnover of company secretaries at Edu Smart. We change corporate governance rating from Amber to Red, lower our FV from Rs220 to Rs110 and downgrade our stance from Neutral to Sell.


See no improvement in stretched cash flow situation
We turned our long-running SELL stance on Educomp (since May 2009) to Neutral in August 2011 citing valuation. Our key thesis then was that an 80% fall in the stock price was factoring in most of the core business and overall governance issues. However, we now see growing reasons to question the sustainability of the core business model and also highlight some new
governance issues which need answering by management. With Educomp’s K- 12 initiative not growing as per expectations and its core business, Smart Class, likely to falter on growth due to funding requirements, we think that there are likely to be further earnings downgrades.


• Incremental securitization of smart class difficult – At the start of the
model, Edu Smart used to get Rs60 for every Rs79 securitized from banks
meaning a cost of debt of 10%. This quickly declined to Rs54 for every
Rs79 securitized resulting in cost of debt of 14% and zero cash balance for
Edu Smart at the end of year 1. While we had expected in May 2011 that
this funding would fall to Rs50 due to rising securitization costs, it has
actually declined to 45. Now either Educomp is paying securitization costs
of 22.25% in return for Rs79 securitized or it is securitising only Rs65 to
keep the rate at 14%. The shortfall of Rs14 implies that Edu Smart will find
it incrementally difficult to pay Educomp, thus stretching its cash flows.

• K-12 segment not that strong as perceived – Our channel checks of
Educomp’s K-12 schools in 2012 suggest no major improvement over 2011,
especially in schools which have been operational for more than 3-4 years.
The only segment that could have helped Educomp in offsetting concerns
of its core business is the K-12 segment, but things are not improving
enough to make any meaningful impact.

• Overall governance issues in the SPE are questionable: In our research
we notice that the statutory auditor of Edu Smart and registered address
of Edu Smart is same. We believe this compromises independence,
especially given any sense of excessive closeness between company and
auditor will naturally concern investors given longstanding concerns about
the structure of Edu Smart. Additionally, we are concerned about the cost
allocation of resource coordinators which should have been booked by
Edu Smart but is being booked by Educomp which is negative for minority
shareholders of Educomp. Furthermore, the high turnover of company
secretaries at Edu Smart also makes us uncomfortable on overall
governance policies.


Valuation: structurally declining model of core business
In our opinion, securitisation has always been a precursor to a big downfall and Educomp must have learnt this by now. Educomp currently trades at a FY13E P/E of 11.6. Our research indicates that growth in the smart class segment (60% of revenues and 90% of EBIT) is set to deteriorate as securitization of smart classes becomes incrementally more difficult. Moreover we are wary about the corporate governance standards of the company. We downgrade our EPS estimates by 50%. SELL Educomp.


To read report in detail: EDUCOMP SOLUTIONS
RISH TRADER

>CIPLA: Dymista approval a tad positive for Cipla (CLSA)

■ Dymista approval a tad positive for Cipla
US FDA approved Meda’s drug Dymista for Allergic Rhinitis. Being a partner, Cipla will benefit through product supplies over the longer term. The product is widely estimated to reach US$300-500m in annual sales over the coming years. Apart from approval (outside North America) related milestone payment (US$5m), we expect gradual increase in Cipla’s sales from product related supplies to Meda. Assuming Cipla supplies product at 10-15% of
sales, it could earn US$50-75m at peak sales.


■ Rupee weakening likely to aid margins
Cipla is one of strongest beneficiaries of a weakening rupee. We expect improving margins over the coming quarters on back of a weak rupee and a low base. We expect strong operating profit growth over coming quarters led by margin expansion and high margin product supplies.


■ Lexapro supplies to Teva, a short term boost
Teva launched Lexapro in March 2012 under six months exclusivity. Cipla benefits from formulation supplies (likely at high margin) during this period. This will help Cipla reported numbers though should be excluded while assigning a price to core earnings multiple. Additionally, a low base in domestic formulations could result in reasonable India growth. AIOCD data on domestic market suggests improving growth for Cipla.


■ Reasonable valuations, Upgrade to O-PF
Post 3QFY12 results, Cipla’s share has corrected more than 10%. We believe margin blip shown in 3Q could correct with multitude of positive triggers like Lexapro supplies and continued weakness in rupee. While we expect modest 12% growth in sales to Rs18.2bn, we see margins expanding by nearly 500bps YoY (low base) and flat QoQ resulting in 47% Ebitda growth and 36% PAT growth to Rs2.9bn (assuming higher tax rate). We upgrade the stock to
O-PF on back of multiple triggers and reasonable valuations while maintaining our target of Rs360/ share based on 19x one year forward earnings.


To read report in detail: CIPLA
RISH TRADER

>HAVELLS INDIA: Sylvania first debt tranche has been refinanced

 FY13E sales growth guidance of 15%-20% and EBITDA margin of 13%-13.5%
Given 9MFY12 performance (revenue/EBITDA/PAT growth of 25%/ 34%/44% and 90bps margin expansion in 9MFY12) and traction in lighting and consumer durable businesses (20%+ growth), FY13 guidance looks easily achievable with high possibility of actual results being closer to the higher end of guidance.


 Sylvania first debt tranche has been refinanced — First tranche of Eur40mn due in April 2012 has been refinanced and negotiations are on for a second tranche of Eur50mn due in April 2013. With current EBITDA run rate of EUR35-36mn (which is growing) and net debt of ~Eur125mn, Sylvania is self sufficient and can service the debt over a slightly longer time horizon.


 Raising target price to Rs633 (from Rs554) — We roll over India business P/E multiple of 18x and Sylvania EV/EBITDA of 5x from March 13E to September 13E. We have also raised our India business EPS estimate marginally by 4%/5% in FY13E/FY14E to factor in slightly higher revenues and 25bps higher EBITDA margin.
There is no change in Sylvania estimates.


 Maintain Buy — Havells has outperformed Sensex by 46%/ 12% over the past 6 months / 3 months respectively. However, business momentum remains robust with healthy EPS growth, cash flow generation and high RoEs. We believe the stock has plenty of steam left and maintain our Buy rating.


■ Risks — Downside risks to our target price include poorer performance from Sylvania, higher commodity prices, unsuccessful new-product launches, increase in competitive intensity and demand slowdown in India


To read report in detail: HAVELLS INDIA
RISH TRADER